Huan Xie to Rats
This is a "connection" page, showing publications Huan Xie has written about Rats.
Connection Strength
1.326
-
Chen Y, Adebusuyi T, Oppong E, Abraham E, Lawrence YM, Ma J, Liang D, Pham SL, McDonald FE, Danaher A, Wu D, Xie H. Method Development and Validation of Liquid Chromatography Tandem Mass Spectrometry for SLP-1A6 in Rat Plasma. J Chromatogr Sci. 2026 Feb 13; 64(3).
Score: 0.138
-
Sarkar M, Du T, Chen Y, Lawrence YVM, Ma J, Khan SA, Oyelere AK, Liang D, Gao S, Xie H. Preclinical Development of GT-14, a Novel Inhibitor of Gai2 Protein: Comprehensive Evaluation of Physicochemical, Metabolic Characteristics and Tissue Distribution. AAPS J. 2025 12 01; 28(1):23.
Score: 0.137
-
Sarkar M, Ma J, Tapadar S, Caggia S, Oyelere AK, Khan SA, Xie H. Development and validation of a sensitive LC-MS/MS assay of GT-14, a novel Gai2 inhibitor, in rat plasma, and its application in pharmacokinetic study. J Pharm Biomed Anal. 2024 Aug 01; 245:116183.
Score: 0.122
-
Chen Y, Gao X, Gupta R, Ma J, Dere R, Liang D, Xie H. Development and Validation of an LC-MS/MS Method for AC1LPSZG and Pharmacokinetics Application in Rats. J Chromatogr Sci. 2022 Jan 01; 60(1):26-34.
Score: 0.104
-
Wang Y, Ma J, Martinez ED, Liang D, Xie H. A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study. J Pharm Biomed Anal. 2020 Nov 30; 191:113587.
Score: 0.095
-
Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H. Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases. Drug Des Devel Ther. 2020; 14:1263-1277.
Score: 0.092
-
Gao X, Tsai RYL, Ma J, Bhupal PK, Liu X, Liang D, Xie H. Determination and validation of mycophenolic acid by a UPLC-MS/MS method: Applications to pharmacokinetics and tongue tissue distribution studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 01; 1136:121930.
Score: 0.090
-
Ekpenyong O, Cooper C, Ma J, Liang D, Olaleye O, Xie H. A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 15; 1097-1098:35-43.
Score: 0.083
-
Liang S, Bian X, Liang D, Sivils JC, Neckers LM, Cox MB, Xie H. Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharm Dev Technol. 2016; 21(1):121-6.
Score: 0.063
-
Bian X, Liang S, John J, Hsiao CH, Wei X, Liang D, Xie H. Development of PLGA-based itraconazole injectable nanospheres for sustained release. Int J Nanomedicine. 2013; 8:4521-31.
Score: 0.059
-
Xie H, Goins B, Bao A, Wang ZJ, Phillips WT. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells. Int J Nanomedicine. 2012; 7:2227-38.
Score: 0.053
-
Liang S, Bian X, Ma J, Arogunjo M, Deorukhkar AA, Krishnan S, Xie H. Development and validation of a sensitive LC/MS/MS method for the determination of ?-tocotrienol in rat plasma: application to pharmacokinetic studies. Biomed Chromatogr. 2013 Jan; 27(1):58-66.
Score: 0.053
-
Xie H, Diagaradjane P, Deorukhkar AA, Goins B, Bao A, Phillips WT, Wang Z, Schwartz J, Krishnan S. Integrin av?3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy. Int J Nanomedicine. 2011; 6:259-69.
Score: 0.049
-
Xie H, Wang ZJ, Bao A, Goins B, Phillips WT. In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. Int J Pharm. 2010 Aug 16; 395(1-2):324-30.
Score: 0.047
-
Asare E, Du T, Chen Y, Emmanuel S, Xie H, Liang D, Gao S. Development and validation of a novel LC-MS/MS method for simultaneous quantification of alvocidib and its glucuronide: application to pharmacokinetic and tissue distribution study in rats. Anal Methods. 2025 Oct 16; 17(40):8142-8149.
Score: 0.034
-
Asare E, Emmanuel S, Du T, Xie H, Liang D, Gao S. Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac. Molecules. 2024 Dec 12; 29(24).
Score: 0.032
-
Rincon Nigro ME, Du T, Gao S, Kaur M, Xie H, Olaleye OA, Liang D. Metabolite Identification of a Novel Anti-Leishmanial Agent OJT007 in Rat Liver Microsomes Using LC-MS/MS. Molecules. 2022 Apr 30; 27(9).
Score: 0.027
-
Rincon Nigro M, Ma J, Awosemo OT, Xie H, Olaleye OA, Liang D. Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study. Int J Environ Res Public Health. 2021 04 27; 18(9).
Score: 0.025
-
John MK, Xie H, Bell EC, Liang D. Development and pharmacokinetic evaluation of a curcumin co-solvent formulation. Anticancer Res. 2013 Oct; 33(10):4285-91.
Score: 0.015
-
Kr?mer S, Xie H, Gaff J, Williamson JR, Tkachenko AG, Nouri N, Feldheim DA, Feldheim DL. Preparation of protein gradients through the controlled deposition of protein-nanoparticle conjugates onto functionalized surfaces. J Am Chem Soc. 2004 May 05; 126(17):5388-95.
Score: 0.008